NYSE - Nasdaq Real Time Price USD

Pfizer Inc. (PFE)

26.00

+0.61

(+2.40%)

At close: April 19 at 4:00 PM EDT

25.90

-0.10

(-0.38%)

After hours: April 19 at 7:59 PM EDT

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Zacks 14 hours ago

PFE
+2.40%
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?

Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?

Investor's Business Daily yesterday

PFE
+2.40%
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

The answer to that question will either make you wince or smile.

Motley Fool yesterday

PFE
+2.40%
Canaan hires Pfizer executive, reels in $100M for biotech investing

The firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist for Pfizer’s emerging science and innovation unit.

BioPharma Dive 2 days ago

PFE
+2.40%
3 No-Brainer Stocks to Buy With $100 Right Now

A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.

Motley Fool 2 days ago

PFE
+2.40%
COMP

^GSPC
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended in March, the healthcare company posted a revenue

Benzinga 3 days ago

JNJ
+1.49%
MRNA

PFE
+2.40%
Why the Market Dipped But Pfizer (PFE) Gained Today

Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.

Zacks 4 days ago

PFE
+2.40%
^GSPC
Is Pfizer Stock a Buy?

The pharmaceutical giant is laying the groundwork for its next heyday.

Motley Fool 4 days ago

PFE
+2.40%
^GSPC
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.

The average yield from these stocks is more than five times the market average.

Motley Fool 4 days ago

PFE
+2.40%
ARCC

T
+1.10%
10 Micro-Cap Healthcare Stocks Insiders Are Buying

In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]

Insider Monkey 5 days ago

PTN

DOMH

FLGC
Large Fund Bets Big on Groceries in the Face of Persistent Inflation

Alaska Permanent, the largest U.S. state wealth fund, tripled its investments in Walmart and Kroger.

Barrons.com 5 days ago

WMT
+0.46%
PFE
+2.40%
F
Two Brothers, a Big Biotech Bet and an $8 Billion Payout

Investors in a hedge fund from Baker Bros. Advisors recently received one of the largest windfalls ever following Pfizer’s purchase of Seagen.

The Wall Street Journal 6 days ago

PFE
+2.40%
The Smartest Dividend Stocks to Buy With $400 Right Now

These three stocks are bargains with great dividends.

Motley Fool 6 days ago

EPD

ARCC

PFE
+2.40%
Big Pharma: Investment Bedrock

Readers weigh in on large pharmaceutical companies, the soaring price of gold, and the techno-industrial megatrend.

Barrons.com 7 days ago

^GSPC

PFE
+2.40%
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.

Zacks 7 days ago

SWAV

PFE
+2.40%
AZN
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever

These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.

Motley Fool 7 days ago

PFE
+2.40%
MO
Is Pfizer Stock the Biggest Bargain in the S&P 500?

When something seems too good to be true it might not be.

Motley Fool 7 days ago

PFE
+2.40%
^GSPC
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

Biotech stocks are one of the hottest investing opportunities in the stock marketlately. The optimism surrounding the industry is evident in the SPDR S&PBiotech ETF’s (NYSEARCA:XBI) 25% bump in value over the past six months, outpacing broader market gains. Moreover, with the impending interest rates cuts, it might be an ideal time to scoop the top biotech players on the dip. Interest in the biotech sphere will continue to grow on the back of several factors, including revolutionary new treatmen

InvestorPlace 8 days ago

MRNA

CELG-RT

VKTX
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

NEW YORK, April 11, 2024--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2024 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 25, 2024. Pfizer has designed the virtual Annual Meeting to ensure that its shareholders who attend the virtual-only Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.

Business Wire 8 days ago

PFE
+2.40%
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?

To extend its existing cash runway and curb cash burn, Novavax (NVAX) initiates multiple restructuring initiatives that are aimed at lowering operating expenses and enhancing profitability.

Zacks 8 days ago

NVAX

PFE
+2.40%

Performance Overview

Return	PFE	S&P 500
YTD	-8.33%	+4.14%
1-Year	-32.58%	+19.55%
3-Year	-24.08%	+18.68%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pfizer Inc. (PFE)

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?

If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today

Canaan hires Pfizer executive, reels in $100M for biotech investing

3 No-Brainer Stocks to Buy With $100 Right Now

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

Why the Market Dipped But Pfizer (PFE) Gained Today

Is Pfizer Stock a Buy?

Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.

10 Micro-Cap Healthcare Stocks Insiders Are Buying

Large Fund Bets Big on Groceries in the Face of Persistent Inflation

Two Brothers, a Big Biotech Bet and an $8 Billion Payout

The Smartest Dividend Stocks to Buy With $400 Right Now

Big Pharma: Investment Bedrock

Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever

Is Pfizer Stock the Biggest Bargain in the S&P 500?

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?

Performance Overview